Myovant Sciences Ltd. ( MYOV) - Stock Earnings

MYOV Quarterly earnings

DateEarningsRevenue
2022Q1 -59.3 million USD 57.6 million USD
2022Q2 -21.2 million USD 116.5 million USD
2022Q3 -45.6 million USD 104.8 million USD

MYOV Yearly earnings

DateEarningsRevenue
2020 -289.0 million USD 0 USD
2021 -255.1 million USD 59.3 million USD
2022 -206.0 million USD 231.0 million USD

MYOV

Price: $26.98

52 week price:
7.67
27.06

Earnings Per Share: -0.92 USD

P/E Ratio: -7.04

Exchange: NYQ

Sector: Healthcare

Industry: Biotechnology

Volume: 539600

Ebitda: -41.0 million

Market Capitalization: 2.6 billion

Links: